Antipsychotics

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• Receptor Blockade: Antipsychotics exert their primary effect via dopamine (D2) receptor antagonism in the central nervous system. First-generation antipsychotics (FGAs) primarily target dopamine blockade; low-potency FGAs are highly sedating, while high-potency FGAs frequently trigger extrapyramidal symptoms (EPS).
• Multi-Receptor Modulation: Second-generation antipsychotics (SGAs) combine dopamine antagonism with serotonin (5-HT2A) receptor antagonism, reducing the incidence of EPS but introducing their own toxidromes, including orthostatic hypotension and anticholinergic effects. Third-generation agents (like aripiprazole) act as partial dopamine agonists.
• The Catastrophic Breakdown: In severe toxicity, excessive dopamine blockade in the nigrostriatal pathway and hypothalamus can precipitate Neuroleptic Malignant Syndrome (NMS). This idiosyncratic reaction results in profound loss of autonomic and thermoregulatory control, driving severe hyperthermia, autonomic instability, and massive calcium release from the sarcoplasmic reticulum, presenting as "lead-pipe" muscle rigidity.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Initial Stabilization: The most common presentation of an antipsychotic overdose is central nervous system (CNS) depression. Immediately prioritize airway management and continuous cardiac monitoring, as these patients are at extreme risk for aspiration and fatal dysrhythmias.
• Managing NMS & Rigidity:
• Instantly withdraw the offending antipsychotic.
• Initiate aggressive IV fluid resuscitation and active external cooling measures.
• Administer Lorazepam 1 to 2 mg IV every 2 to 4 hours as needed for sedation and to reduce rigidity.
• If severe rigidity persists, administer Dantrolene (1.0 to 2.5 mg/kg IV load, followed by 1 mg/kg IV every 6 hours) OR Bromocriptine (2.5 mg PO 3 to 4 times daily).
• Managing Extrapyramidal Symptoms (EPS): Treat dystonia and akathisia with first-line agents like benztropine or diphenhydramine. Use IV lorazepam for refractory cases.
• Airway Protection in NMS: Consider early endotracheal intubation, utilizing nondepolarizing neuromuscular blocking agents, especially if significant hypersalivation or severe rigidity restricts ventilation.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• The "Can't-Miss" Mimics:
• Serotonin Syndrome (SS): Closely mimics NMS but is differentiated by hyperreflexia and clonus rather than rigidity.
• Tricyclic Antidepressant (TCA) Toxicity: Shares features of QTc prolongation, AMS, and anticholinergic symptoms.
• Malignant Hyperthermia, Sympathomimetic toxicity, and Malignant Catatonia.
• Prioritized Diagnostic Workup:
• Electrolytes & Renal Panel: Check Potassium, Calcium, Magnesium, and Sodium, as derangements exacerbate antipsychotic-induced QT prolongation.
• Creatine Phosphokinase (CPK): Mandatory to evaluate for rhabdomyolysis in any patient with rigidity or suspected NMS.
• Co-Ingestant Screen: Always obtain a serum acetaminophen level and bedside blood glucose.
• Note: Quantitative serum antipsychotic levels are not readily available and are completely unhelpful in acute ED management.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The Toxic ECG Checklist: You must perform a 12-lead ECG on all patients with suspected toxicity to evaluate for cardiovascular threats. Actively measure the QTc interval, as antipsychotic toxicity (and therapeutic use) notoriously causes QT prolongation, precipitating fatal Torsades de Pointes. Look for widening of the QRS complex.
• Chest Radiograph (CXR): Obtain a portable CXR in any hypoxic patient or patient with depressed mentation to rule out aspiration pneumonitis, a frequent complication of antipsychotic-induced CNS depression.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The NMS vs. SS Reflex Rule: Clinical differentiation dictates disposition and treatment.
• If the patient exhibits "lead-pipe" muscle rigidity and bradyreflexia, the diagnosis is NMS.
• If the patient exhibits hyperreflexia, clonus, myoclonus, or opsoclonus (random eye saccades), the diagnosis is Serotonin Syndrome.
• Admission Criteria: Patients with profound CNS depression, hemodynamic instability, new ECG abnormalities (such as QTc prolongation), or any signs of NMS require immediate admission to a monitored intensive care unit (ICU) setting.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• The Clozapine Trap: Pitfall: Failing to recognize the unique lethality of clozapine. Critical Action: Clozapine is uniquely associated with life-threatening agranulocytosis. You must immediately stop the medication and aggressively investigate and treat any potential infections.
• The Toxidrome Confusion: Pitfall: Administering dopamine agonists to a patient with Serotonin Syndrome, or relying purely on fever to diagnose NMS. Critical Action: Accurately perform a reflex exam. NMS features extreme stiffness and elevated CPK; Serotonin Syndrome features hyperkinesia.
• The Iatrogenic Prolongation Trap: Pitfall: Administering chemical restraints like droperidol or haloperidol to an undifferentiated agitated patient without considering their cardiac risks. Critical Action: Be aware of the black-box warnings for QT prolongation and Torsades de Pointes associated with these agents.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzwords: "Lead-pipe muscle rigidity," "autonomic instability," "elevated CPK," and "altered mental status." Exam Answer: Neuroleptic Malignant Syndrome.
• Buzzword: "Agranulocytosis" or a severe, unexplained infection in a patient taking an atypical antipsychotic. Exam Answer: Clozapine toxicity.
• Distractor: An exam question presents an antipsychotic overdose and offers "obtain quantitative serum drug levels" as the next best step. Correction: Serum antipsychotic levels do not correlate with acute toxicity and should not guide emergency management.
• High-Yield Fact: NMS is an idiosyncratic reaction, meaning it can occur at therapeutic doses and is not strictly dose-dependent.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Initial Resuscitation: "Given the patient’s severe CNS depression and history of antipsychotic overdose, my immediate priority is to protect the airway to prevent aspiration. I will prepare for endotracheal intubation, establish IV access, and place the patient on continuous cardiac monitoring to evaluate for QTc prolongation or Torsades de Pointes."
• The Diagnostic Physical Exam: "I am specifically testing the patient's reflexes and muscle tone. The presence of 'lead-pipe' rigidity and bradyreflexia confirms Neuroleptic Malignant Syndrome rather than Serotonin Syndrome. I need STAT labs including a CPK, electrolytes including calcium and magnesium, and an acetaminophen level."
• The Targeted Therapy: "To manage the NMS, I am stopping all offending antipsychotics immediately. I will start aggressive IV fluid hydration, initiate active external cooling, and administer IV lorazepam. I will also consult for the administration of Dantrolene or Bromocriptine and arrange for immediate ICU admission."